Fuse Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 16, 2020 at 05:23 pm
Share
Fuse Medical, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was USD 5.738 million compared to USD 5.716 million a year ago. Operating income was USD 106,756 compared to operating loss of USD 3.102 million a year ago. Net income was USD 80,484 compared to net loss of USD 4.064 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.06 a year ago. For the nine months, sales was USD 14.385 million compared to USD 15.562 million a year ago. Operating loss was USD 1.539 million compared to USD 3.857 million a year ago. Net loss was USD 1.626 million compared to USD 4.717 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.07 a year ago.
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.
FUSE MEDICAL, INC. 
